Facebook Linkedin RSS Twitter Youtube
Home 2024

Astellas

Cytiva Launches Next-Gen Cell Therapy Manufacturing Platform
Bioprocessing

Cytiva Launches Next-Gen Cell Therapy Manufacturing Platform

GTC 2024: Nvidia Highlights AI ‘Revolution’ in Drug Discovery, Genomics
Artificial Intelligence

GTC 2024: Nvidia Highlights AI ‘Revolution’ in Drug Discovery, Genomics

Prime Editing for Isogenic iPSCs, PRINT, Universal In Vivo CAR T Editing, Biogen Q4 Results Disappoint; Andrea Choe
Bioprocessing

Prime Editing for Isogenic iPSCs, PRINT, Universal In Vivo CAR T Editing, Biogen Q4 Results Disappoint; Andrea Choe

Astellas and Kelonia Partner for $800M In Vivo CAR T Cell Therapies
Cancer

Astellas and Kelonia Partner for $800M In Vivo CAR T Cell Therapies

As Biopharma Giants Reshape the Field, Cognition Therapeutics Sees a Place for Its Alzheimer’s Drug
Drug Discovery

As Biopharma Giants Reshape the Field, Cognition Therapeutics Sees a Place for Its Alzheimer’s Drug

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly
Bioprocessing

Conscious Re-Coupling: M&A Comes Back Surely, If Slowly

BPI News: Opening Keynote Offers Hopeful Outlook for Cell and Gene Therapy
Bioprocessing

BPI News: Opening Keynote Offers Hopeful Outlook for Cell and Gene Therapy

Astellas to Invest More than €330 Million in New Facility in Ireland
Bioprocessing

Astellas to Invest More than €330 Million in New Facility in Ireland

AI, Cell/Gene Therapy, Precision Medicine Drive Bullish Biotech Investment
Artificial Intelligence

AI, Cell/Gene Therapy, Precision Medicine Drive Bullish Biotech Investment

Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline
Drug Discovery

Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline

123...13Page 1 of 13
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.